A detailed history of Franklin Resources Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 14,801 shares of ITOS stock, worth $110,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,801
Previous 14,801 -0.0%
Holding current value
$110,563
Previous $151,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.09 - $17.97 $330,861 - $589,254
-32,791 Reduced 68.9%
14,801 $151,000
Q2 2024

Aug 14, 2024

BUY
$10.33 - $18.09 $115,220 - $201,775
11,154 Added 30.61%
47,592 $706,000
Q1 2024

May 13, 2024

BUY
$9.89 - $13.64 $360,371 - $497,014
36,438 New
36,438 $497,000
Q2 2023

Aug 11, 2023

BUY
$12.93 - $18.05 $156,090 - $217,899
12,072 New
12,072 $159,000
Q2 2022

Aug 11, 2022

SELL
$16.57 - $35.1 $109,461 - $231,870
-6,606 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$31.92 - $47.45 $210,863 - $313,454
6,606 New
6,606 $212,000
Q1 2021

May 13, 2021

SELL
$30.86 - $44.2 $2.62 Million - $3.76 Million
-85,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$17.57 - $32.92 $1.49 Million - $2.8 Million
85,000 New
85,000 $2.1 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $266M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.